Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Associations between common ECG abnormalities and out-of-hospital cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Repeatability and Reproducibility of Neonatal Echocardiography: The Copenhagen Baby Heart Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Exercise cardiovascular magnetic resonance imaging allows differentiation of low-risk pulmonary arterial hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. One of its most devastating complications is the development of thromboembolism leading to fatal or disabling stroke. Oral anticoagulation (OAC, warfarin) is the standard treatment for stroke prevention in patients with AF with an increased stroke risk. However, there are several obstacles to long-term OAC therapy, including the risk of serious bleeding, several drug-drug interactions and the need for frequent blood testing. Although newer oral anticoagulants have been developed, these drugs also face issues of major bleeding and non-compliance. Therefore, alternative treatment options for stroke prevention in patients with AF with a high stroke risk are needed. Percutaneous left atrial appendage (LAA) occlusion is an evolving therapy, which should be taken into consideration in those patients with non-valvular AF with a high stroke risk and contraindications for OAC. This article aims to discuss the rationale for LAA closure, the available LAA occlusion devices and their clinical evidence until now. Moreover, we discuss the importance of proper patient selection, the role of various imaging techniques and the need for a more tailored postprocedural antithrombotic therapy.

Original languageEnglish
JournalOpen Heart
Volume1
Issue number1
Pages (from-to)e000020
DOIs
Publication statusPublished - 2014

ID: 45028014